Key Takeaways Oceaneering won a 3-year, $80M-$90M contract from Esso Angola for subsea services starting July 1, 2025. The deal includes advanced ROVs, IWOCS, hydrate remediation, inspection and satellite systems. OII's local subsidiaries support workforce development, aligning with Angola's national content goals.Oceaneering International (OII) , a global leader in engineered services and products, has once again demonstrated its unmatched capability in offshore operations by securing a significant contr ...

Core Viewpoint - SiriusXM is shifting its business strategy towards an ad-supported subscription model to drive revenue and retain customers in a competitive audio entertainment market [3][12]. Group 1: New Subscription Plan - The company launched its first ad-supported subscription plan, SiriusXM Play, priced at under $7 per month, offering a limited selection of commercials across music, sports, news, and talk shows [2][4]. - This new plan aims to convert free trial users into long-term subscribers, particularly targeting drivers who do not renew after their trial period [6][7]. Group 2: Market Position and Strategy - SiriusXM is focusing on its core in-car radio business, which constitutes 90% of its customer base, while also planning to expand the ad-supported option to nearly 100 million vehicles by the end of 2025 [4][13]. - The company is reallocating resources from high-cost streaming audiences to enhance its in-car offerings and advertising strategy [12][13]. Group 3: Financial Performance - In the most recent quarter, SiriusXM reported $2.07 billion in revenue, a 4% decline year-over-year, with net income falling to $204 million from $241 million [15]. - The company generated approximately $1.8 billion in total ad revenue for 2024, with $394 million reported in the latest quarter, reflecting a decline from the previous year [16]. Group 4: Competitive Landscape - SiriusXM faces increasing competition from streaming services like Spotify and Apple Music, which are gaining traction in the in-car audio space [11]. - The company is drawing parallels to Netflix's previous struggles with subscriber growth and its eventual shift to an ad-supported model [9][10].

Core Points - IMUNON, Inc. has received approval from the Nasdaq Hearing Panel for an exception to complete its compliance plan, allowing the company to maintain its Nasdaq listing [1][2] - The Nasdaq Hearing Panel noted that IMUNON has achieved compliance with the Equity Rule through recent fundraising activities and will implement a compliance plan to meet minimum shareholder equity and bid price requirements [2][3] - The Panel approved a tailored exception for IMUNON to regain compliance within a designated timeframe, rather than the full 180 days initially requested [3] Company Overview - IMUNON is a clinical-stage biotechnology company focused on developing innovative treatments that utilize the body's natural mechanisms to generate effective responses against various diseases [5] - The company is advancing its non-viral DNA technology, with its lead clinical program, IMNN-001, being a DNA-based immunotherapy for advanced ovarian cancer [6] - IMNN-001 has completed multiple clinical trials, including a Phase 2 trial, and the company has also conducted a first-in-human study for its COVID-19 booster vaccine, IMNN-101 [6]

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced it anticipates benefitting from the announcement that Vestel recently entered a strategic partnership with VIDAA, the world’s second largest and fastest-growing smart TV platform. Nexxen has a strategic partnership with VIDAA, which is set to expire at the end of 2026, and currently ho ...

Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference Plus will also host an educational symposium with leading experts titled, “Reimagining Your Approach to Leptomeningeal Metastases” HOUSTON, July 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announces the oral presentat ...

Momentum builds behind global expansion strategy as brand aims to accelerate global net unit growth to achieve 2,000 international restaurants by 2028DUBLIN, Ohio, July 15, 2025 /PRNewswire/ -- The Wendy's Company announced today the finalization of two new franchise agreements that will add up to 190 new Wendy's® restaurants across Italy and Armenia, marking a significant step forward in advancing the brand's strategic priority to accelerate global net unit growth. These commitments support Wendy's goal to ...

The Federal Reserve is likely to cut rates in September, and, on top of that, President Trump is urging Fed Chairman Powell to resign, potentially to be replaced by someone more dovish. This favors risky assets like equities, but oneAs a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading, or informational reasons. For this purpose, I am not a classical equity researcher from the financial sector, but, I come from the IT world as the Directo ...

Core Viewpoint - City View Green Holdings Inc. is set to acquire up to a 20% interest in Arkenyield, a digital asset yield platform, for a total investment of $575,000, reflecting its strategy to expand in the digital finance sector, particularly in stablecoins [1][2][10] Group 1: Acquisition Details - The acquisition will involve purchasing up to 20% of Arkenyield's issued and outstanding securities for $575,000, which will be paid through a mix of common shares and a convertible debenture [2][9] - The convertible debenture will have a five-year term and can be converted into common shares at a price of $0.05 per share [9] - The transaction is contingent upon City View completing its proposed change of business (COB) and fulfilling customary closing conditions, including due diligence [3][4] Group 2: Strategic Shift - City View is transitioning from a "cannabis issuer" to an "investment issuer," which is classified as a fundamental change under Canadian Securities Exchange (CSE) policy [2] - This strategic shift will require CSE and shareholder approval before the transaction can be finalized [11] Group 3: Arkenyield Overview - Arkenyield is a digital asset yield platform that focuses on generating returns from stablecoins, utilizing proprietary Concentrated Liquidity Market-Making (CLMM) strategies [7][10] - The platform aims to meet the growing institutional demand for stablecoin yield infrastructure, recognizing stablecoins as essential to global financial systems [7][10] Group 4: Future Plans - City View is considering integrating cryptocurrency into its treasury management, potentially allocating capital to digital assets, including stablecoins, to enhance stability and liquidity [5] - The company plans to engage Arkenyield for specialized treasury management services to navigate the digital asset landscape [5]

中国AI眼镜行业丨研究报告 前言： 距离下一个"iPhone时刻"还有多远 "iPhone时刻" 用来描述那些标志性、划时代的时刻——当某个技术产品或创新的出现，彻底改变了某个行 业或领域的格局，并且深刻影响了人们的日常生活和社会结构。 而站在今天的视角，我们不禁要问：下一个"iPhone时刻"何时出现？ AI眼镜不仅是科技的产物，更可能成为一种新的生活方式，一种无形中打破人与世界之间的界限的媒介。无 论是增强现实带来的全新体验，还是人工智能所赋予的智慧，它们都在这副眼镜里找到了完美的容身之地。 我们可以想象，在不远的将来，它将不再只是一个工具，而是融入我们生活的伙伴，成为我们与世界、与他 人、与自我之间沟通的桥梁。 但这一切，还距离我们究竟有多远？是几年的努力，还是更长时间的沉淀？也许今天的技术还在试探，设计 还在蜕变，市场还在观察。 但AI眼镜，或许正悄然走在这条路上，等待着那个"iPhone时刻"的到来，等待着未来的一道曙光，帮助我 们"看清"整个世界。 AI眼镜定义及分类概览 人工智能赋能传统眼镜产品，功能性及实用性日趋完善 AI 眼镜是一种创新型可穿戴设备，其在传统眼镜产品的基础上增加了人工智能技术 ...

Available ✅ List of data contributors to the equity Consolidated Tape Provider → https://t.co/qhVvCKsSyz.The list also includes #trading venues that can choose to transmit data to the equity #CTP and opt-in to the mandatory data contribution regime. https://t.co/C4jzSTjBqy ...